Pinnacle Wealth Planning Services, Inc. Amgen Inc Transaction History

Pinnacle Wealth Planning Services, Inc.

$748 Million
Q2 2025

A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 1,284 shares of AMGN stock, worth $379,473. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,284

Previous 2,039 37.03%

Holding current value

$379,473

Previous $635,000 43.62%

% of portfolio

0.05%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$262.28 - $309.85 $198,021 - $233,936	-755 Reduced 37.03%	1,284 $358,000
Q1 2025 May 15, 2025	BUY	$258.59 - $327.36 $24,048 - $30,444	93 Added 4.78%	2,039 $635,000
Q4 2024 Feb 06, 2025	SELL	$258.78 - $328.31 $191,755 - $243,277	-741 Reduced 27.58%	1,946 $507,000
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $1,546 - $1,686	5 Added 0.19%	2,687 $865,000
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $6,306 - $7,663	-24 Reduced 0.89%	2,682 $837,000
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $3,226 - $3,894	-12 Reduced 0.44%	2,706 $769,000
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $1,789 - $2,019	-7 Reduced 0.26%	2,718 $782,000
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $34,546 - $42,890	158 Added 6.16%	2,725 $732,000
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $59,995 - $70,943	-280 Reduced 9.83%	2,567 $569,000
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $63,446 - $77,331	281 Added 10.95%	2,847 $688,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $46,035 - $58,493	-201 Reduced 7.26%	2,566 $673,000
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $30,751 - $34,681	137 Added 5.21%	2,767 $624,000
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $66,905 - $74,454	290 Added 12.39%	2,630 $640,000
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $183,528 - $203,031	837 Added 55.69%	2,340 $566,000
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $49,322 - $56,444	-248 Reduced 14.16%	1,503 $338,000
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $257,058 - $301,175	-1,211 Reduced 40.88%	1,751 $372,000
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $22,657 - $25,136	-97 Reduced 3.17%	2,962 $722,000
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $77,446 - $90,251	-349 Reduced 10.24%	3,059 $761,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $30,076 - $35,816	-139 Reduced 3.92%	3,408 $784,000
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $25,107 - $27,921	107 Added 3.11%	3,547 $901,000
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $12,659 - $15,535	64 Added 1.9%	3,440 $812,000
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $201,921 - $267,803	1,108 Added 48.85%	3,376 $683,000
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $68,494 - $88,038	362 Added 18.99%	2,268 $546,000
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $82,702 - $99,094	475 Added 33.19%	1,906 $368,000
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $33,506 - $39,277	201 Added 16.34%	1,431 $264,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $83,019 - $93,580	-459 Reduced 27.18%	1,230 $234,000
Q4 2018 Mar 01, 2019	BUY	$178.4 - $208.25 $4,638 - $5,414	26 Added 1.56%	1,689 $330,000
Q3 2018 Feb 28, 2019	BUY	$185.29 - $208.89 $370 - $417	2 Added 0.12%	1,663 $345,000
Q2 2018 Feb 28, 2019	BUY	$166.05 - $186.51 $25,405 - $28,536	153 Added 10.15%	1,661 $307,000
Q1 2018 Feb 28, 2019	BUY	$169.43 - $198.0 $197,047 - $230,274	1,163 Added 337.1%	1,508 $257,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $58,232 - $65,063	345	345 $60,000

Others Institutions Holding AMGN

# of Institutions

3,274

Shares Held

442M

Call Options Held

6.15M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.

Account

Pinnacle Wealth Planning Services, Inc. Amgen Inc Transaction History